Jane Street’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-114,016
Closed -$1.2M 12508
2025
Q4
$1.34M Sell
114,016
-248,820
-69% -$2.68M ﹤0.01% 5547
2025
Q3
$2.8M Buy
362,836
+27,431
+8% +$192K ﹤0.01% 4340
2025
Q2
$2.45M Buy
335,405
+224,374
+202% +$1.81M ﹤0.01% 4096
2025
Q1
$1.05M Sell
111,031
-14,020
-11% -$175K ﹤0.01% 5473
2024
Q4
$2.06M Sell
125,051
-64,037
-34% -$995K ﹤0.01% 4052
2024
Q3
$2.79M Sell
189,088
-159,399
-46% -$2.49M ﹤0.01% 3861
2024
Q2
$4.83M Buy
348,487
+80,727
+30% +$1.14M ﹤0.01% 3004
2024
Q1
$4.21M Buy
267,760
+88,218
+49% +$1.36M ﹤0.01% 2881
2023
Q4
$2.9M Buy
179,542
+53,419
+42% +$874K ﹤0.01% 3696
2023
Q3
$1.55M Sell
126,123
-47,657
-27% -$709K ﹤0.01% 4466
2023
Q2
$2.79M Buy
173,780
+133,188
+328% +$2.19M ﹤0.01% 3627
2023
Q1
$707K Sell
40,592
-33,110
-45% -$472K ﹤0.01% 5699
2022
Q4
$681K Buy
73,702
+58,873
+397% +$549K ﹤0.01% 5624
2022
Q3
$128K Buy
+14,829
New +$147K ﹤0.01% 8509
2022
Q2
Sell
-97,692
Closed -$933K 10462
2022
Q1
$1.19M Buy
97,692
+52,182
+115% +$1.1M ﹤0.01% 5777
2021
Q4
$1.55M Sell
45,510
-12,232
-21% -$479K ﹤0.01% 5001
2021
Q3
$2.79M Buy
57,742
+40,286
+231% +$1.86M ﹤0.01% 3809
2021
Q2
$789K Sell
17,456
-70,134
-80% -$3.11M ﹤0.01% 6345
2021
Q1
$4.22M Buy
87,590
+78,997
+919% +$4.11M ﹤0.01% 2655
2020
Q4
$463K Sell
8,593
-7,205
-46% -$326K ﹤0.01% 5861
2020
Q3
$583K Buy
+15,798
New +$587K ﹤0.01% 4923
2019
Q1
Sell
-348,184
Closed -$4.39M 5412
2018
Q4
$4.39M Buy
+348,184
New +$5.19M 0.01% 1027

Other funds holding NEO

Jane Street's NEO Position: Q1 2026 in Review

Jane Street sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 114,016 shares — an estimated $1.2M sold.

Jane Street first reported a position in NEO in Q4 2018 and held it in 22 quarters. The position peaked at $4.83M in Q2 2024. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Jane Street reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 114,016 NeoGenomics shares in Q1 2026, an estimated $1.2M.
  • Jane Street first reported a position in NeoGenomics in Q4 2018 and held it in 22 quarters.
  • Jane Street's NeoGenomics position peaked at $4.83M in Q2 2024.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.